TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35793342

Group type: EXPERIMENTAL
Intervention: Physical exercise (morning jogging)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melatonin supplement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of physical exercise and melatonin supplement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 33773532

Group type: EXPERIMENTAL
Intervention: Exercise rehabilitation program (two-week duration)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Routine chemotherapy care (control group)
Number of subjects: 79
Study: 32015007

Group type: EXPERIMENTAL
Intervention: 6-month ART dispensing
Number of subjects: 79

Group type: COMPARATOR
Intervention: 3-month ART dispensing
Number of subjects: 79
Study: 35565901

Group type: EXPERIMENTAL
Intervention: Maternal undernutrition
Number of subjects: 1431

Group type: EXPERIMENTAL
Intervention: Maternal higher education
Number of subjects: 1431
Study: 34473402

Group type: EXPERIMENTAL
Intervention: Daily PrEP regimen (TDF/FTC 300 mg/200 mg)
Number of subjects: 119

Group type: COMPARATOR
Intervention: On-demand PrEP regimen (TDF/FTC 300 mg/200 mg)
Number of subjects: 119
Study: 34269239

Group type: EXPERIMENTAL
Intervention: In situ hardening biphasic calcium phosphate (BCP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Xenograft particles
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both treatment groups (BCP and xenograft)
Number of subjects: 42
Study: 33091461

Group type: EXPERIMENTAL
Intervention: Tisseel®
Number of subjects: 147

Group type: COMPARATOR
Intervention: Hemopatch®
Number of subjects: 147
Study: 35249977

Group type: EXPERIMENTAL
Intervention: Supine position (group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Seated position (group 2)
Number of subjects: 40
Study: 33357325

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including inpatient pharmacist‐led medication reconciliation, coordination of care, postdischarge phone calls, and postdischarge primary care visit.
Number of subjects: 1679

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 1679

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention.
Number of subjects: 1679
Study: 35381390

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) therapy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 32918266

Group type: EXPERIMENTAL
Intervention: Permethrin 1%
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Lindane 1%
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Dimeticone 4%
Number of subjects: 444

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 444
Study: 32511749

Group type: EXPERIMENTAL
Intervention: Tenecteplase 0.4 mg/kg (maximum 40 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alteplase 0.9 mg/kg (maximum 90 mg)
Number of subjects: 40
Study: 35213344

Group type: EXPERIMENTAL
Intervention: Proprioception training
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (common rehabilitation training)
Number of subjects: 45
Study: 32739102

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BT) intraanal sphincteric injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bowel management program (BMP) and senna based laxatives (SBL)
Number of subjects: 40
Study: 35278093

Group type: EXPERIMENTAL
Intervention: Tät II treatment focused on pelvic floor muscle training (PFMT) and bladder training (BT)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Information app (control group)
Number of subjects: 122
Study: 32408933

Group type: EXPERIMENTAL
Intervention: Experienced hoist operators
Number of subjects: 16

Group type: COMPARATOR
Intervention: Novice hoist operators
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Experienced hoist operators (in wind)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Novice hoist operators (in wind)
Number of subjects: 16
Study: 32460583

Group type: EXPERIMENTAL
Intervention: Telehealth communication skills training
Number of subjects: 36

Group type: COMPARATOR
Intervention: In-person communication skills training
Number of subjects: 36
Study: 33926904

Group type: EXPERIMENTAL
Intervention: CONSORT extension for randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CONSORT 2010 statement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement
Number of subjects: 0

Group type: COMPARATOR
Intervention: REporting of studies Conducted using Observational Routinely collected Data (RECORD) statement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eight items modified from the CONSORT 2010 statement and five new items
Number of subjects: 0
Study: 34281641

Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: PLIAGLIS
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 14

Group type: COMPARATOR
Intervention: Distal limb (treated and control limbs)
Number of subjects: 14
Study: 32186050

Group type: EXPERIMENTAL
Intervention: De Qi group (deep needling with thick needles and manipulation, n = 17)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Non-De Qi group (shallow needling with thin needles and no manipulation, n = 51)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups (De Qi and non-De Qi)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: De Qi occurrence time
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Duration of De Qi
Number of subjects: 68
Study: 33470755

Group type: EXPERIMENTAL
Intervention: Transdermal 17-beta estradiol (TE) 100 mcg/d
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Oral raloxifene 60 mg/d
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Proprietary phytoestrogen compound, Rimostil 1000 mg twice/d
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 32416181

Group type: EXPERIMENTAL
Intervention: Elevated baseline serum uric acid (sUA) levels (>6 mg/dL)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Baseline serum uric acid levels
Number of subjects: 212
Study: 35180465

Group type: EXPERIMENTAL
Intervention: ToR lead time of 6-60 seconds
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ToR lead time of 16-30 seconds
Number of subjects: 31
Study: 34817964

Group type: EXPERIMENTAL
Intervention: Glass hybrid (GH; EQUIA Forte Fil/EQUIA Forte Coat, GC)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Adhesive/nanofilled resin composite restorations (RC; OptiBond FL, Kerr/Filtek Supreme XTE, 3M Oral Care)
Number of subjects: 88
Study: 34013819

Group type: EXPERIMENTAL
Intervention: SLE with prior severe organ manifestation
Number of subjects: 34

Group type: COMPARATOR
Intervention: SLE without prior severe organ manifestation
Number of subjects: 34
Study: 32245584

Group type: EXPERIMENTAL
Intervention: PRO-AGE scoring system
Number of subjects: 5025
Study: 33844620

Group type: EXPERIMENTAL
Intervention: Multipass low fluence, high-frequency 755-nm Alexandrite laser
Number of subjects: 30

Group type: COMPARATOR
Intervention: High fluence, low-frequency 1064-nm long-pulsed Nd: YAG laser
Number of subjects: 30
Study: 32479556

Group type: EXPERIMENTAL
Intervention: Instrumentality-based pro-diversity beliefs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Actual instrumentality of ethnic diversity
Number of subjects: 0
Study: 35505308

Group type: EXPERIMENTAL
Intervention: Predictive score for atypical pathogens (AP)
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Age < 75 years
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Heart failure
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Absence of chest pain
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Natremia < 135 mmol/L
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Contracting the disease in autumn
Number of subjects: 580
Study: 33132228

Group type: EXPERIMENTAL
Intervention: Dabigatran (150 or 110 mg twice daily)
Number of subjects: 594

Group type: COMPARATOR
Intervention: Aspirin (100 mg once daily)
Number of subjects: 594
Study: 35389963

Group type: EXPERIMENTAL
Intervention: BREAKS (intermittent walking for 2 min every 20 min at 6.4 km·h‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: SIT (sitting continuously for 5.5 hours)
Number of subjects: 10
Study: 32126988

Group type: EXPERIMENTAL
Intervention: Questionnaire development process
Number of subjects: 103000
Study: 33459115

Group type: EXPERIMENTAL
Intervention: Dual-task gait training (DTGT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Single-task gait training (STGT)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both DTGT and STGT
Number of subjects: 36
Study: 34410769

Group type: EXPERIMENTAL
Intervention: Feedback condition (n = 147) with access to patient-generated outcome (ORS) and alliance information.
Number of subjects: 280

Group type: COMPARATOR
Intervention: Treatment as usual (TAU; n = 133).
Number of subjects: 280
Study: 32083994

Group type: EXPERIMENTAL
Intervention: Restrictive RBC transfusion strategy (Hb threshold < 70 g/L)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Liberal RBC transfusion strategy (Hb threshold < 90 g/L)
Number of subjects: 300
Study: 36049354

Group type: EXPERIMENTAL
Intervention: Deep learning-based EEG analysis
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Deep learning-based EEG analysis with certainty factor ≥ 60%
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Deep learning-based EEG analysis with certainty factor ≥ 75%
Number of subjects: 358
Study: 34032387

Group type: EXPERIMENTAL
Intervention: Extended contact with community-dwelling older adults and positive theoretical education
Number of subjects: 55

Group type: COMPARATOR
Intervention: Positive theoretical education only (Control group)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both groups (Intervention and Control)
Number of subjects: 55
Study: 34393020

Group type: EXPERIMENTAL
Intervention: Oral rotavirus vaccine (RVV)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Gut microbiome composition
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Bacteroides thetaiotaomicron
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Random forest models
Number of subjects: 158
Study: 32142484

Group type: EXPERIMENTAL
Intervention: C+COX‐2‐Is (convention plus COX‐2 inhibitors)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 190
Study: 35786298

Group type: EXPERIMENTAL
Intervention: 5-session psychological intervention in primary care
Number of subjects: 220
Study: 33650616

Group type: EXPERIMENTAL
Intervention: MC‐LASSO‐PLS
Number of subjects: 0

Group type: COMPARATOR
Intervention: LASSO‐PLS
Number of subjects: 0

Group type: COMPARATOR
Intervention: MC‐PLS
Number of subjects: 0

Group type: COMPARATOR
Intervention: PLS
Number of subjects: 0
Study: 32114699

Group type: EXPERIMENTAL
Intervention: Interprofessional education through case-based learning sessions
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (no interprofessional education)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Interprofessional education
Number of subjects: 113
Study: 35312376

Group type: EXPERIMENTAL
Intervention: 2D radiomics model
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: 3D radiomics model
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Integrated nomogram
Number of subjects: 172
Study: 33712274

Group type: EXPERIMENTAL
Intervention: Bevacizumab (bev)
Number of subjects: 1249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1249
Study: 33560501

Group type: EXPERIMENTAL
Intervention: Keyhole technique
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Sugarbaker technique
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Sandwich technique
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Specific intra-abdominal keyhole technique with funnel-shaped mesh
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Other techniques
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 235
Study: 35101724

Group type: EXPERIMENTAL
Intervention: Multimodal usual care plus neurodynamic intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Multimodal usual care alone
Number of subjects: 32
Study: 34011203

Group type: EXPERIMENTAL
Intervention: BSS at 2.7°C (Group 2)
Number of subjects: 214

Group type: COMPARATOR
Intervention: BSS at operating room temperature (Group 1)
Number of subjects: 214
Study: 32045773

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 1.5 g intra-articular combined with 1.5 g intravenous
Number of subjects: 74

Group type: COMPARATOR
Intervention: Hemocoagulase atrox 1 U intra-articular combined with 1 U intravenous
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Hemocoagulase atrox
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 74
Study: 34049378

Group type: EXPERIMENTAL
Intervention: Intravenous somatostatin plus rectal indomethacin (100 mg suppository)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group (rectal indomethacin only)
Number of subjects: 376
Study: 33499257

Group type: EXPERIMENTAL
Intervention: Diet - fish and seafood consumption
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Overweight and obesity
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: High educational level and older age
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA)
Number of subjects: 479
Study: 35392995

Group type: EXPERIMENTAL
Intervention: quetiapine (n = 71)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: lithium (n = 50)
Number of subjects: 121
Study: 33930244

Group type: EXPERIMENTAL
Intervention: Chronic hepatitis B (CHB) patients
Number of subjects: 30
Study: 35134142

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforations (MOPs) - two 5 mm deep MOPs performed prior to space closure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control - no MOPs applied
Number of subjects: 20
Study: 34374960

Group type: EXPERIMENTAL
Intervention: vNOTES hysterectomy
Number of subjects: 26

Group type: COMPARATOR
Intervention: LESS hysterectomy
Number of subjects: 26
Study: 32577819

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 77

Group type: COMPARATOR
Intervention: VKA
Number of subjects: 77
Study: 34647708

Group type: EXPERIMENTAL
Intervention: Duodenal-Jejunal Bypass Liner (DJBL)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control (intensive medical care without DJBL)
Number of subjects: 170
Study: 33148224

Group type: COMPARATOR
Intervention: Urban residence
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Rural residence
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Participants aged below 14 years
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Participants with both parents alive
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Participants whose fathers had skilled occupations
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Participants who watched TV every day
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Rural participants
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Urban participants
Number of subjects: 1157

Group type: EXPERIMENTAL
Intervention: Overall knowledge comparison
Number of subjects: 1157

Group type: EXPERIMENTAL
Intervention: Age at menarche over the last two decades
Number of subjects: 1157
Study: 35881014

Group type: EXPERIMENTAL
Intervention: Cortical allograft
Number of subjects: 120

Group type: COMPARATOR
Intervention: PEEK interbody spacers
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 33260247

Group type: EXPERIMENTAL
Intervention: Abemaciclib
Number of subjects: 1
Study: 32460818

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin and co-amoxiclav for at least 5 days after switching from intravenous antibiotics within 12-24 hours of starting IV therapy.
Number of subjects: 230

Group type: COMPARATOR
Intervention: Intravenous antibiotics (piperacillin/tazobactam or meropenem) continued for at least 48 hours.
Number of subjects: 230
Study: 35435878

Group type: EXPERIMENTAL
Intervention: Classical Massage (CM)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Benson Relaxation Exercise (BRE)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study: 34379375

Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching (DS)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Myofascial Foam Rolling (FR)
Number of subjects: 14
Study: 33327334

Group type: EXPERIMENTAL
Intervention: SVV-guided fluid management
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional fluid therapy
Number of subjects: 60
Study: 36333665

Group type: EXPERIMENTAL
Intervention: Pain intensity measured on a 0-100 scale
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pain intensity measured on a 0-10 scale
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pain intensity measured on a 0-3 scale
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pain intensity measured on a 0-4 scale
Number of subjects: 12
Study: 33582852

Group type: EXPERIMENTAL
Intervention: Submucous resection (group A, n = 45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Combined submucous diathermy and outfracture (group B, n = 45)
Number of subjects: 90
Study: 32378802

Group type: EXPERIMENTAL
Intervention: Common hepatic duct clamping using atraumatic bulldog clamp after biliary division (Group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No clamping (Group II)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 40
Study: 35003796

Group type: EXPERIMENTAL
Intervention: Experimental group (trochlear dysplasia model)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 33332313

Group type: EXPERIMENTAL
Intervention: Florida Sleeve technique (FS group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: David technique (D group)
Number of subjects: 64
Study: 34372752

Group type: EXPERIMENTAL
Intervention: High repetition arm training (6 sessions between 3 and 6 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 33688946

Group type: EXPERIMENTAL
Intervention: [18F]fluorodeoxyglucose (FDG) PET‐CT and endoscopic ultrasonography (EUS) with guided fine‐needle aspiration biopsy
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: EUS
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: PET‐CT
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (standard follow-up visits)
Number of subjects: 89
Study: 36344005

Group type: EXPERIMENTAL
Intervention: Restrictive oxygen strategy (lowest dosage of oxygen >21% to ensure SpO2 of 94%)
Number of subjects: 1420

Group type: COMPARATOR
Intervention: Liberal oxygen strategy (12-15 L O2/min or FiO2 = 0.6-1.0)
Number of subjects: 1420
Study: 32967392

Group type: EXPERIMENTAL
Intervention: Scrambler Therapy (ST)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (standard pain management drugs)
Number of subjects: 80
Study: 35241690

Group type: EXPERIMENTAL
Intervention: Oral verapamil
Number of subjects: 0
Study: 32059974

Group type: EXPERIMENTAL
Intervention: ARM + ve preservation ALND
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional ALND
Number of subjects: 98
Study: 35988198

Group type: COMPARATOR
Intervention: Conventional treatment + BAL
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional treatment + ST + BAL
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional treatment + ST
Number of subjects: 40
Study: 34949968

Group type: EXPERIMENTAL
Intervention: Preventive nursing intervention (MHD group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional nursing service (routine group)
Number of subjects: 100
Study: 33370739

Group type: EXPERIMENTAL
Intervention: Traditional Chinese music therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Painting therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 120
Study: 35677742

Group type: EXPERIMENTAL
Intervention: Traditional osteoporosis risk factors
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Previous fracture
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Asian race
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Vitamin D therapy requirement
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Prior cardiovascular event
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Serum albumin
Number of subjects: 135
Study: 32655047

Group type: EXPERIMENTAL
Intervention: Dietary counseling
Number of subjects: 87
Study: 35099543

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) for 3 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control period for 3 weeks
Number of subjects: 30
Study: 36058207

Group type: EXPERIMENTAL
Intervention: Advanced Hybrid Closed Loop (AHCL) therapy
Number of subjects: 82

Group type: COMPARATOR
Intervention: Multiple daily injections of insulin plus isCGM
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: AHCL group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Multiple daily injections of insulin plus isCGM group
Number of subjects: 82
Study: 33350891

Group type: EXPERIMENTAL
Intervention: MRI-based synthetic CT (sCT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: T1-weighted MRI
Number of subjects: 30
Study: 36395746

Group type: EXPERIMENTAL
Intervention: Killed oral cholera vaccine (OCV) with a second dose after 2 weeks
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Killed oral cholera vaccine (OCV) with a second dose after 6 months
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Killed oral cholera vaccine (OCV) with a second dose after 11.5 months
Number of subjects: 186
Study: 35360485

Group type: COMPARATOR
Intervention: Sodium hyaluronate eye drops (Control)
Number of subjects: 92
Study: 34209004

Group type: EXPERIMENTAL
Intervention: Suspension training (n = 12)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Traditional training (n = 13)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-exercise control group (n = 11)
Number of subjects: 36